Freeman EW, Sondheimer SJ. Premenstrual Dysphoric Disorder: Recognition and Treatment. Prim Care Companion J Clin Psychiatry. 2003 Feb. 5 (1):30-39. [QxMD MEDLINE Link].
Hantsoo L, Epperson CN. Premenstrual Dysphoric Disorder: Epidemiology and Treatment. Curr Psychiatry Rep. 2015 Nov. 17 (11):87. [QxMD MEDLINE Link]. [Full Text].
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar MH. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res. 2010 Dec. 15 (Suppl 1):401-5. [QxMD MEDLINE Link]. [Full Text].
Gynecologic pain: dysmenorrhea, acute and chronic pelvic pain, endometriosis, and premenstrual syndrome. Emans SJH, Laufer MR, eds. Emans, Laufer, Goldstein's Pediatric and Adolescent Gynecology. 6th ed. Philadelphia: Wolters Kluwer; 2012. Chap 13.
Gehlert S, Chang CH, Hartlage S. Symptom patterns of premenstrual dysphoric disorder as defined in the Diagnostic and Statistical Manual of Mental Disorders-IV. J Womens Health. 1999 Jan-Feb. 8 (1):75-85. [QxMD MEDLINE Link].
Rossignol AM, Bonnlander H. Prevalence and severity of the premenstrual syndrome. Effects of foods and beverages that are sweet or high in sugar content. J Reprod Med. 1991 Feb. 36 (2):131-6. [QxMD MEDLINE Link].
Bertone-Johnson ER, Whitcomb BW, Missmer SA, Manson JE, Hankinson SE, Rich-Edwards JW. Early life emotional, physical, and sexual abuse and the development of premenstrual syndrome: a longitudinal study. J Womens Health (Larchmt). 2014 Sep. 23 (9):729-39. [QxMD MEDLINE Link]. [Full Text].
Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE. Cigarette smoking and the development of premenstrual syndrome. Am J Epidemiol. 2008 Oct 15. 168 (8):938-45. [QxMD MEDLINE Link]. [Full Text].
Braverman PK. Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol. 2007 Feb. 20 (1):3-12. [QxMD MEDLINE Link].
Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999 Mar-Apr. 8 (2):122-8. [QxMD MEDLINE Link].
Masho SW, Adera T, South-Paul J. Obesity as a risk factor for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2005 Mar. 26 (1):33-9. [QxMD MEDLINE Link].
Choi SH, Hamidovic A. Association between smoking and premenstrual syndrome: a meta-analysis. Front Psychiatry. 2020. 11:575526. [QxMD MEDLINE Link].
Cleckner-Smith CS, Doughty AS, Grossman JA. Premenstrual symptoms. Prevalence and severity in an adolescent sample. J Adolesc Health. 1998 May. 22 (5):403-8. [QxMD MEDLINE Link].
Nobles CJ, Thomas JJ, Valentine SE, Gerber MW, Vaewsorn AS, Marques L. Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample. Int J Eat Disord. 2016 Jul. 49 (7):641-50. [QxMD MEDLINE Link].
Bertone-Johnson ER, Whitcomb BW, Rich-Edwards JW, Hankinson SE, Manson JE. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am J Epidemiol. 2015 Dec 15. 182 (12):1000-9. [QxMD MEDLINE Link].
Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res. 1996 Nov 15. 65 (2):97-106. [QxMD MEDLINE Link].
Johnson SR. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol. 2004 Oct. 104 (4):845-59. [QxMD MEDLINE Link].
Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull. 1997. 33 (4):771-4. [QxMD MEDLINE Link].
Forrester-Knauss C, Zemp Stutz E, Weiss C, Tschudin S. The interrelation between premenstrual syndrome and major depression: results from a population-based sample. BMC Public Health. 2011 Oct 12. 11:795. [QxMD MEDLINE Link]. [Full Text].
Sanfilippo JS, Muram D, Dewhurst J, Lee PA, eds. Pediatric and Adolescent Gynecology. 2nd ed. Philadelphia: Saunders; 2001. 433-50.
Freeman EW. Therapeutic management of premenstrual syndrome. Expert Opin Pharmacother. 2010 Dec. 11 (17):2879-89. [QxMD MEDLINE Link].
Maharaj S, Trevino K. A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder. J Psychiatr Pract. 2015 Sep. 21 (5):334-50. [QxMD MEDLINE Link].
Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005 Sep. 106 (3):492-501. [QxMD MEDLINE Link].
Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol. 1994 Nov. 84 (5):779-86. [QxMD MEDLINE Link].
Diegoli MS, da Fonseca AM, Diegoli CA, Pinotti JA. A double-blind trial of four medications to treat severe premenstrual syndrome. Int J Gynaecol Obstet. 1998 Jul. 62 (1):63-7. [QxMD MEDLINE Link].
Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. Am J Psychiatry. 1999 Sep. 156 (9):1403-8. [QxMD MEDLINE Link].
Freeman EW, Rickels K, Sondheimer SJ, Denis A, Pfeifer S, Weil S. Nefazodone in the treatment of premenstrual syndrome: a preliminary study. J Clin Psychopharmacol. 1994 Jun. 14 (3):180-6. [QxMD MEDLINE Link].
Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study. Arch Fam Med. 1999 Jul-Aug. 8 (4):328-32. [QxMD MEDLINE Link].
Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005 Dec. 72 (6):414-21. [QxMD MEDLINE Link].
Pearlstein TB, Stone AB, Lund SA, Scheft H, Zlotnick C, Brown WA. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. J Clin Psychopharmacol. 1997 Aug. 17 (4):261-6. [QxMD MEDLINE Link].
Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998 Jan 22. 338 (4):209-16. [QxMD MEDLINE Link].
Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria. Biol Psychiatry. 1999 Feb 1. 45 (3):313-20. [QxMD MEDLINE Link].
Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health. 2003 Aug. 6 (3):203-9. [QxMD MEDLINE Link].
Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol. 2001 Jul. 185 (1):227-35. [QxMD MEDLINE Link].
Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol. 1998 Aug. 179 (2):444-52. [QxMD MEDLINE Link].
Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998 Nov. 7 (9):1157-65. [QxMD MEDLINE Link].
Wilson SA. Calcium therapy for treating PMS. J Fam Pract. 1998 Dec. 47 (6):410-1. [QxMD MEDLINE Link].
Yakir M, Kreitler S, Brzezinski A, Vithoulkas G, Oberbaum M, Bentwich Z. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study. Br Homeopath J. 2001 Jul. 90 (3):148-53. [QxMD MEDLINE Link].
Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group. JAMA. 1997 Sep 24. 278 (12):983-8. [QxMD MEDLINE Link].
Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999 May 22. 318 (7195):1375-81. [QxMD MEDLINE Link].
Wyatt KM, Dimmock PW, O'Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2002. CD001396. [QxMD MEDLINE Link].
Halbreich U. Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD: effective but not enough. CNS Spectr. 2008 Jul. 13 (7):566-72. [QxMD MEDLINE Link].
Romano S, Judge R, Dillon J, Shuler C, Sundell K. The role of fluoxetine in the treatment of premenstrual dysphoric disorder. Clin Ther. 1999 Apr. 21 (4):615-33; discussion 613. [QxMD MEDLINE Link].
Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med. 1995 Jun 8. 332 (23):1529-34. [QxMD MEDLINE Link].
Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry. 1998 Feb. 59 (2):76-80. [QxMD MEDLINE Link].
Ford O, Lethaby A, Roberts H, Mol BW. Progesterone for premenstrual syndrome. Cochrane Database Syst Rev. 2012 Mar 14. 3:CD003415. [QxMD MEDLINE Link].
Marjoribanks J, Brown J, O'Brien PM, Wyatt K. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev. 2013 Jun 7. CD001396. [QxMD MEDLINE Link]. [Full Text].
Ismaili E, Walsh S, O'Brien PMS, Bäckström T, Brown C, Dennerstein L, et al. Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder. Arch Womens Ment Health. 2016 Dec. 19 (6):953-958. [QxMD MEDLINE Link].
Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG. 2008 Mar. 115 (4):515-9. [QxMD MEDLINE Link].
Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome?. Control Clin Trials. 1996 Feb. 17 (1):60-8. [QxMD MEDLINE Link].
Chou PB, Morse CA, Xu H. A controlled trial of Chinese herbal medicine for premenstrual syndrome. J Psychosom Obstet Gynaecol. 2008 Sep. 29 (3):185-92. [QxMD MEDLINE Link].
Bertone-Johnson ER, Chocano-Bedoya PO, Zagarins SE, Micka AE, Ronnenberg AG. Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population. J Steroid Biochem Mol Biol. 2010 Jul. 121 (1-2):434-7. [QxMD MEDLINE Link].
Evans SM, Foltin RW, Fischman MW. Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder. Appetite. 1999 Jun. 32 (3):331-49. [QxMD MEDLINE Link].
Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol. 2003 May. 188 (5 Suppl):S56-65. [QxMD MEDLINE Link].
El-Lithy A, El-Mazny A, Sabbour A, El-Deeb A. Effect of aerobic exercise on premenstrual symptoms, haematological and hormonal parameters in young women. J Obstet Gynaecol. 2015 May. 35 (4):389-92. [QxMD MEDLINE Link].
Yesildere Saglam H, Orsal O. Effect of exercise on premenstrual symptoms: a systematic review. Complement Ther Med. 2020 Jan. 48:102272. [QxMD MEDLINE Link].
Jarvis CI, Lynch AM, Morin AK. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother. 2008 Jul. 42 (7):967-78. [QxMD MEDLINE Link].
Sharma B, Misra R, Singh K, Sharma R, Archana. Comparative study of effect of anuloma-viloma (pranayam) and yogic asanas in premenstrual syndrome. Indian J Physiol Pharmacol. 2013 Oct-Dec. 57 (4):384-9. [QxMD MEDLINE Link].